









Markets
/
Stocks
/
nasdaq-scph
/

scPharmaceuticals Inc

SCPH

View Detailed Chart

5.170USD

+0.090+1.77%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

259.97MMarket Cap

LossP/E TTM



scPharmaceuticals Inc

5.170

+0.090+1.77%

Overview Company Financials

Financials

Intraday

30m

Today

+1.77%

5 Days

-7.68%

1 Month

+30.23%

6 Months

+61.56%

Year to Date

+46.05%

1 Year

+14.38%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 5 analysts

BUY

Current Rating

15.600

Target Price

201.74%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

scPharmaceuticals Inc

SCPH

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(3)

Buy(4)

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.046

Neutral

RSI(14)

59.985

Neutral

STOCH(KDJ)(9,3,3)

20.729

Sell

ATR(14)

0.337

High Vlolatility

CCI(14)

-9.390

Neutral

Williams %R

57.810

Sell

TRIX(12,20)

1.407

Sell

StochRSI(14)

15.690

Oversold

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

5.272

Sell

MA10

5.368

Sell

MA20

4.881

Buy

MA50

4.277

Buy

MA100

3.468

Buy

MA200

3.525

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. The Companay’s pipeline programs include SCP-111 (furosemide injection) 80mg/mL is an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home.

Ticker SymbolSCPH

CompanyscPharmaceuticals Inc

CEOMr. John H. Tucker

Websitehttps://www.scpharmaceuticals.com/